Open AccessElective cardioversion of atrial fibrillation is safe without transesophageal echocardiography in patients treated with non-vitamin K antagonist oral anticoagulants: Multicenter experience
Author(s) -
Iwona Gorczyca−Michta,
Beata UziębłoŻyczkowska,
Anna Szpotowicz,
Magdalena Chrapek,
Paweł Krzesiński,
Bernadetta Bielecka,
Agnieszka Woronowicz-Chróściel,
Paweł Wałek,
Małgorzata Krzciuk,
Beata Wożakowska−Kapłon
Publication year - 2021
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0010
Subject(s) - medicine , dabigatran , rivaroxaban , atrial fibrillation , apixaban , vitamin k antagonist , cardioversion , cardiology , warfarin , anesthesia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom